Home / Inspections / 1274509

FDA Inspection 1274509 — NYU Langone Health, Transplantation & Cellular Therapy

NYU Langone Health, Transplantation & Cellular Therapy — FEI 2470026

The FDA completed an inspection of NYU Langone Health, Transplantation & Cellular Therapy on June 27, 2025 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1250142 (VAI Thu Sep 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1177868 (NAI Fri Aug 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1015463 (VAI Thu May 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 922842 (VAI Thu Apr 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 822206 (VAI Mon Mar 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources